Table 2.
Patient Characteristics
| Characteristic | Part I N = 26 | Part II Cohort A N = 28 | Part II Cohort B N = 26 |
|---|---|---|---|
|
| |||
| Age | |||
| Median | 63.3 (29–76) | 57. 6 (23–80) | 60 (40–83) |
|
| |||
| Sex | |||
| Male | 20 | 13 | 15 |
| Female | 6 | 15 | 11 |
|
| |||
| Race | |||
| Caucasian | 23 | 23 | 24 |
| African American | 1 | 0 | 1 |
| Asian | 2 | 2 | 1 |
| Other | 0 | 3 | 0 |
|
| |||
| Primary Site | |||
| Breast | 4 | 4 | 4 |
| Colorectal | 2 | 4 | 2 |
| Endometrium | 2 | 1 | 1 |
| Melanoma | 1 | 0 | 1 |
| Non-Small Cell Lung | 3 | 0 | 1 |
| Non-Hodgkin Lymphoma | 1 | 0 | 0 |
| Pancreas | 1 | 4 | 4 |
| Head & Neck Cancer | 1 | 0 | 1 |
| Bladder | 1 | 0 | 0 |
| Renal | 1 | 2 | 1 |
| Ovarian | 0 | 3 | 1 |
| Prostate | 0 | 1 | 4 |
| Other Primary Sites* | 9 | 9 | 6 |
*
pleural mesothelioma, adenoid cystic carcinoma, carcinoid of lung, hepatocellular, sarcoma, peritoneal mesothelioma, small bowel, apocrine, thymoma, unknown primary